Stories | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Stories

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (13)
  • 2024 (6)
  • 2023 (8)
  • 2022 (9)
  • 2021 (15)
  • 2020 (4)
  • 2019 (12)
  • 2018 (4)
Clear All Results
STORY

DEA and Federal Partners Support Continuity of Patient Treatment

Diciembre 28, 2023
DEA is committed to making sure patients can get the care they need in the event a doctor or medical facility is unable to provide treatment due to enforcement action against the medical provider. On October 5, 2023, DEA arrested a nurse practitioner in Buffalo, New York, on charges of...
Diciembre 28, 2023
STORY

DEA Adds Precursor Chemicals Used to Make Illicit Fentanyl to the Special Surveillance List

Octubre 30, 2023
Fentanyl is the greatest threat facing Americans today. It is a threat to our public health, our public safety, and our national security, and it is the cause of the most devastating drug crisis in United States’ history. The U.S. Drug Enforcement Administration (DEA) is committed to using every tool...
Octubre 30, 2023
STORY

A Message From DEA Administrator Anne Milgram

Octubre 06, 2023
Washington, D.C. – The U.S. Drug Enforcement Administration (DEA) is focused on saving American lives by defeating the cartels responsible for bringing fentanyl into our country. The threat of fentanyl is deadlier and more pervasive than ever before. When I joined DEA in 2021, DEA laboratory testing indicated 4 out...
Octubre 06, 2023
STORY

Five Synthetic Benzodiazepine Drugs Deemed Imminent Hazard to Public Safety

Septiembre 25, 2023
On July 26, 2023, DEA temporarily scheduled five synthetic benzodiazepine substances – etizolam, flualprazolam, clonazolam, flubromazolam, and diclazepam – in schedule I of the Controlled Substances Act (CSA). Individuals who handle these substances will now be subject to regulatory controls, as well as to administrative, civil, and criminal sanctions applicable...
Septiembre 25, 2023
STORY

DEA and DHS Issue Joint Update on Sources of Illicit Xylazine

Septiembre 22, 2023
The U.S. Drug Enforcement Administration and the U.S. Department of Homeland Security are updating the American public on the ongoing threat of illicit xylazine. In April 2023, the White House Office of National Drug Control Policy (ONDCP) designated fentanyl adulterated or associated with xylazine as an emerging threat to the...
Septiembre 22, 2023
STORY

Revised Regulation Allows DEA-Registered Pharmacies to Transfer Electronic Prescriptions at a Patient’s Request

Septiembre 01, 2023
Patients now have the ability to request their electronic prescription be transferred to another pharmacy without having to go back to their practitioner to initiate the request. This revised regulation went into effect on Monday, August 28, 2023. At a patient’s request, a DEA-registered retail pharmacy can now transfer an...
Septiembre 01, 2023
STORY

Albuquerque Employers Benefit from DEA Training and Resources Available Through Operation Engage

Agosto 18, 2023
Following a successful Family Summit on fentanyl in September of 2022, the El Paso Division outreach team has been working with Bernalillo County leadership to create more prevention education opportunities for employers. So, in July as part of Operation Engage, the DEA sponsored a CADCA training which was hosted at...
Agosto 18, 2023
STORY

Overdose Death Investigations Challenge DEA Agents to Bring Justice

Febrero 08, 2023
Deaths from illicit drugs, especially fentanyl, are at historic highs. It’s why Drug Enforcement Administration St. Louis Division investigators are committed to protecting Americans and saving lives by pursuing those responsible. They aim to make sure as many drug traffickers involved in those deaths as possible, get an appearance in...
Febrero 08, 2023
STORY

Aliviane Addiction Recovery Center Sponsors One Pill Can Kill Billboard Campaign in El Paso

Julio 06, 2022
Every year, Aliviane, (an addiction recovery center in El Paso) organizes an annual conference to highlight the prevalent issues in the community, and to educate parents on various health and legal consequences of substance use. “Our annual conference aims at bridging the gaps of knowledge or highlighting prevalent issues in...
Julio 06, 2022
STORY

Spreading the Word:

Junio 07, 2022
The current fentanyl crisis is a major issue in communities all across the United States – communities of every type, cultural affiliation, and socioeconomic status. The DEA’s Washington Division has been taking a proactive approach to this issue in the Nation’s Capital – partnering with their federal, state, and local...
Junio 07, 2022
Showing 1 - 10 of 17 results

Paginación

  • Current page 1
  • Página 2
  • Siguiente página ›
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster